Multiple Sclerosis Flashcards
What happens to the brain with the natural course of MS?
brain atrophy
What is most likely responsible for disability in MS?
Axonal involvement
Diagnosis of MS depends on demonstrating what?
attacks of neurologic dysfunction disseminated in time and space
Most patients with MS begin as what type?
Relapsing- Remitting
Untreated pts w/ RRMS typically progress to what type of MS?
Progressive
Name four interferons used for MS treatment.
Avonex, Rebif, Betaseron, Extavia
Name three treatments for acute MS
Corticosteroids, plasmaphoresis, ACTH
What is the MOA of interferons in MS
inhibit T cell activation, shift from Th1 to Th2 (non-inflammatory), inhibit lymphocyte movement into CNS, apoptosis of T cells, IFN antagonism
What interferons are high dose, low dose?
Avonex - low dose
Rebif, Extavia, Betasteron- high dose
What are added benefits of Rebif over other interferons?
reduces disability
What two interferons work on IFN beta-1a?
Rebif, Avonex
What two interferons work on IFN beta-1b?
Extavia, Betasteron
Of the interferons what has the greatest likelihood of causing Neutralizing antibodies?
Betasteron
SE of avonex
lesser than other corticosteroids because lesser dose
mild anemia, elevated LFTs, hypothyroid
monitor LFTs every 6 months
SE of Rebif, Betasteron, Extavia
anemia, leukopenia, elevated LFTs, hypothyroid, menstrual irregularities, depression
monitor LFTs every 3 months
What are interferons used to treat?
RRMS
What is MOA of glatiramer acetate (Copaxone)?
causes T cell apoptosis, induces anti-inflammatory Th2 cells, induces regulatory T cells
What problem occurs with NAB caused by use of an IFN?
All IFNs can no longer be used to treat because of cross reactivity
When should you begin treating MS?
EARLY, before diagnosis with MS but high risk of developing MS by MRI criteria
SE of glatiramer acetate (copaxone)?
mild injection site reaction
Anxiety-like reactions- chest tightness, SOB (Not related to heart problem)
What isglatiramer acetate (copaxone) used to treat?
RRMS
What is Natalizumab used to treat?
RRMS, considered 3rd line now with oral agents in use
What are the SE of natalizumab?
PML (jc virus)
acute uticaria
systemic hypersensitivity reaction
headache, dizziness, fatigue, arthralgia, rigors
More common in pts with NAB
When would you use ACTH?
treat acute MS attack in person with allergy to corticosteroids or poor IV access
MOA of Natalizumab?
Binds VLA4 inhibiting leukocyte migration across BB barrier
What is fingolimod used to treat?
RRMS
Fingolimod MOA?
prodrug, sequesters circulating lymphocytes in secondary lymphoid organs via internalization of receptors on lymphocytes
SE of Fingolimod?
Bradycardia and heart block (EKG for 6 hrs) Macular edema (eye exam before treatment adn at 3 months)--> don't use in Diabetics
Reduced FEV1, increased LFTs, lymphopenia, leukopenia, asthenia, back pain, blurred vision, headache dizziness, infections
What must a patient be immune to before prescription of Fingolomid?
VZV
What is teriflunomide (Aubagio) use to treat?
RRMS
MOA of teriflunomide (Aubagio)?
Selective dihydro-orotate dehydrogenase inhibitor
blocks de-novo pyramidine synthesis, reducing T and B cell proliferation and function in response to autoantigens
SE of teriflunomide (Aubagio)?
hepatotoxicity, teratogenicity, nausea, decreased hair density
Dimethyl fumarate MOA?
activates Nrf2 pathway and induces antioxidant enzyme production (decreases oxidative stress)
Induces TH1–> Th2 shift
SE of dimethyl fumarate?
N/V/D, stomach pain, flushing
What are SE of corticosteroid use?
ST: insomnia, mood changes, fluid retention, epigastric pain, hypertension
LT: osteoporosis, cushingoid, secondary malignancies
In regards to MS what does a Gd+ lesion and a T2 lesion represent?
Gd+ lesions are new lesions that convert to Th2 after 2 months
Name four immunosuppressants used to treat SPMS?
Azathioprine, Methotrexate, Cyclophosphamide, Mycophenolate mofetil
SE of immunosuppressants?
Systemic toxicity, monitor for blood changes
What is Mitoxantrone used to treat?
SPMS and RRMS (2nd line)
SE of Mitoxantrone?
Cardiac toxicity- decreased LVEF and irreversible CHF, risk increases w/ cumulative dosing
Acute leukemia
N/V, alopecia, increased infection risk, menstrual irregularities
MOA of Mitoxantrone?
Broad immune suppression of macrophages, B & T cells. Reduces disease progression and disability.